University of Toledo Medical Center CRS

Site Details

LOCATION

3000 Arlington Avenue

Ruppert Health Center Bldg.

Mail Stop 1186

Toledo, OH. 43614

Get Directions

SiteType

CRS

CRS Coordinator

Jennifer Gilmore

jennifer.gilmore@utoledo.edu

419-383-6761

CRS Leader

Joan Duggan

joan.duggan@utoledo.edu

419-383-4328

Site Trials

HIV comorbidities and complications

Closed to accrual

A5332: REPRIEVE Trial

In this study, people between the ages of 40 and 75 with HIV will be randomized (like flipping a coin) to take the pill pitavastatin OR a placebo (non-active pill) to see if pitavastatin can help prevent heart disease and death in people who are taking HIV medication. You will not know if you are taking pitavastatin or placebo. The REPRIEVE trial will enroll about 7500 people from several countries.